The present invention relates generally to amino acid derivatives and to methods of making the same. In particular, the invention relates to compounds bearing a stereochemical identity, that is, the same stereochemistry, with the chiral &agr;-carbon of D-&agr;-amino acids and their use in methods of therapy, including the treatment of inflammatory diseases, and to compositions and enantiomeric mixtures containing them.
P,Nsp3-bidentate chiral ligands bearing spiro[indane-1,2′-pyrrolidine] backbone were prepared in gram scale for the first time. Pd complexes of these air-stable amino phosphine ligands could catalyze asymmetric allylic substitutions of malonate-, alcohol-, and amine-type nucleophiles in up to 97% ee and 99% yield. A crystal structure of [Pd(II)(η3-1,3-diphenylallyl)(ligand)]PF6 indicated possible transition
silyloxycyclopropane to iodonium salts in the presence of Pd(OAc)2 (2 mol %) and (4:1) to afford β-substituted ester. Alternatively, carbonylative coupling of silyloxypropane was carried out by slow addition of silyloxypropanes to iodonium salts under CO(1 atm) at room temperature in aqueous medium. The palladium-catalyzedcoupling of ketene trimethylsilyl acetals with iodonium salts is also described.
[EN] COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES<br/>[FR] COMPOSES ET INHIBITEURS DE PHOSPHOLIPASES
申请人:UNIV QUEENSLAND
公开号:WO2002008189A1
公开(公告)日:2002-01-31
The present invention relates generally to amino acid derivatives and to methods of making the same. In particular, the invention relates to compounds bearing a stereochemical identity, that is, the same stereochemistry, with the chiral α-carbon of D-α-amino acids and their use in methods of therapy, including the treatment of inflammatory diseases, and to compositions and enantiomeric mixtures containing them.